CUV 0.55% $14.47 clinuvel pharmaceuticals limited

Ann: SCENESSE in DNA Repair, page-5

  1. 830 Posts.
    lightbulb Created with Sketch. 1125
    “We expect the first results in 2021 and will monitor the safety of the XP patients receiving SCENESSE® day to day. It is
    of high relevance to confirm the role of SCENESSE® in UV radiation damage regeneration and will improve the general
    understanding how to reduce skin cancer risk for many of us,” Dr Bilbao said.

    A couple of big things in that last paragraph. One is results are very close - next year - as a lot of boxes have been ticked off here already by existing data that has been captured. Second is about reducing the risk of skin cancer which is a MAJOR health problem - so treatment for a much more prevalent and also terrible disease to follow???
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.47
Change
-0.080(0.55%)
Mkt cap ! $725.1M
Open High Low Value Volume
$14.60 $14.60 $14.32 $361.5K 24.98K

Buyers (Bids)

No. Vol. Price($)
16 719 $14.46
 

Sellers (Offers)

Price($) Vol. No.
$14.47 65 6
View Market Depth
Last trade - 13.16pm 10/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.